DIAGNOSIS OF INSULIN RESISTANCE IN PATIENTS AT HIGH CARDIOVASCULAR RISK: FOCUS ON PEPTIDE HORMONE GHRELIN
https://doi.org/10.15372/ATER20190303
Abstract
The aim of the research: to determine the diagnostic value of ghrelin in patients with myocardial infarction.
Material and methods. 200 patients (130 men and 70 women) were examined whose average age was 61.4 ± 1.12 years with a diagnosis of myocardial infarction (MI) with an ST segment elevation. On the 1st and 12th day of the development of MI in the blood serum, the content of glucose, insulin, C-peptide, free fatty acids and ghrelin was determined.
Results. Insulin resistance (IR) is a fairly common and characteristic phenomenon for patients with high cardiovascular risk. The presence of insulin resistance in people with MI was associated with more pronounced disorders of carbohydrate and lipid metabolism compared with patients in whom MI was without signs of IR. Ghrelin levels were significantly reduced in patients with MI during the entire period of hospitalization. It was established that ghrelin was the most sensitive and specific marker of IR, especially in the early stages of MI. The determination of ghrelin in combination with free fatty acids increases their diagnostic significance in relation to IR.
Conclusion: ghrelin deficiency is one of the significant factors for the presence of IR in myocardial infarction. The results of the study indicate the potential suitability of ghrelin as a new diagnostic marker of metabolic disorders in cardiovascular diseases.
About the Authors
E. V. Belik
Research Institute for Complex Issues of Cardiovascular Disease
Russian Federation
Russian Federation
O. V. Gruzdeva
Research Institute for Complex Issues of Cardiovascular Disease; Kemerovo State Medical Academy of Minzdrav of Russia
Russian Federation
Russian Federation
Yu. A. Dyleva
Research Institute for Complex Issues of Cardiovascular Disease
Russian Federation
Russian Federation
T. R. Dolinchik
Kemerovo Regional Clinical Cardiology Clinic named after Academician L.S. Barbarash
Russian Federation
Russian Federation
A. A. Kuz'mina
Research Institute for Complex Issues of Cardiovascular Disease
Russian Federation
Russian Federation
E. E. Bychkova
Kemerovo State Medical Academy of Minzdrav of Russia
Russian Federation
Russian Federation
References
1. Lazzeri C., Sori A., Chiostri M., Gensini G.F., Valente S. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention // Eur. J. Anaesthesiol. 2009. Vol. 26. Р. 856–862.
2. Rask-Madsen C., Kahn C. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease // Arterioscler. Thromb. Vasc. Biol. 2012. Vol. 32. Р. 2052–2059.
3. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.J. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans // J. Clin. Endocrinol. Metab. 2000. Vol. 85. Р. 2402–2410.
4. Gruzdeva O., Uchasova E., Dyleva Y., Belik E., Kashtalap V., Barbarash O. Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure // Diabetes Metab. Syndr. Obes. 2013. Vol. 6. Р. 103–111.
5. Lee H.M., Wang G., Englander E.W., Kojima M., Greeley G.H. Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: Enteric distribution, ontogeny, influence of endocrine, and dietary manipulations // Endocrinology. 2002. Vol. 143. Р. 185–190.
6. Yada T., Dezaki K., Sone H., Koizumi M., Damdindorj B., Nakata M., Kakei M. Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential // Curr. Diabetes. Rev. 2008. Vol. 4. Р. 18–23.
7. Blom W.A., Stafleu A., de Graaf C., Kok F.J., Schaafsma G., Hendriks H.F.J. Ghrelin response to carbohydrate- enriched breakfast is related to insulin // Am. J. Clin. Nutr. 2005. Vol. 81. P. 367–375.
8. Doogue M.P., Begg E.J., Moore M.P., Lunt H., Pemberton C.J., Zhang M. Metformin increases plasma ghrelin in type 2 diabetes // Br. J. Clin. Pharmacol. 2009. Vol. 68. Р. 875–882.
9. Sinha D.P., Ahmed S., Baneerjee A.K., Das M., Hassan H. Significance of an index of insulin resistance in non-diabetic patients with impaired fasting glucose with acute myocardial infarction and its correlation to short term outcome // Indian Heart J. 2009. Vol. 61 (1). Р. 40–43.
10. Альмухамбетова Р.К., Жангелова Ш.Б., Токсанбаева Г.Т., Мусаев А.А., Кодасбаев А.Т., Мусаев А.Т., Оспанов Б.Ж., Альмухамбетов М.К., Жангелова М.Б., Рустамова Ф.Е., Арипов М.А., Ералиева Л.Т., Батырбаева Д.Ж., Ложкин А.А., Бекту- раева С.У. Синдром инсулинорезистентности у больных кардиологического профиля // Соврем. пробл. науки и образования. 2016. (3). URL: http://www.science-education.ru/ru/article/view?id=24413(дата обращения: 21.06.2019).
11. Clavijo L.C., Pinto T.L., Kuchulakanti P.K., Torguson R., Chu W.W., Satler L.F., Kent K.M., Suddath W.O., Pichard A.D., Waksman R. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications // Cardiovasc. Revasc. Med. 2006. Vol. 7 (1). Р. 7–11.
12. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., Suryapranata H., Zijlstra F., van 't Hof A.W. Hyperglycemia is an important predictor of impaired coronary fl ow before reperfusion therapy in ST-segment elevation myocardial infarction // J. Am. Coll. Cardiol. 2005. Vol. 45, N 7. Р. 999–1002.
13. Vestergaard E.T., Hansen T.K., Gormsen L.C., Jakobsen P., Moller N., Christiansen J.S., Jorgensen J.O. Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects // Am. J. Physiol. Endocrinol. Metab. 2007. Vol. 292. Р. E1829–E1836.
14. Guido M., Romualdi D., de Marinis L., Porcelli T., Giuliani M., Costantini B., Lanzone A. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin // Fertil. Steri. 2007. Vol. 88. Р. 125–130.
15. López M., Lage R., Saha A.K., Pérez-Tilve D., Vázquez M.J., Varela L., Sangiao-Alvarellos S., Tovar S., Raghay K., Rodríguez-Cuenca S., Deoliveira R.M., Castañeda T., Datta R., Dong J.Z., Culler M., Sleeman M.W., Alvarez C.V., Gallego R., Lelliott C.J., Carling D., Tschöp M.H., Diéguez C., Vidal-Puig A. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin // Cell Metab. 2008. Vol. 7. Р. 389–399.
16. van der Lely A.J., Tschop M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin // Endocr. Rev. 2004. Vol. 25. Р. 426–457.
17. Chang L., Ren Y., Liu X., Li W.G., Yang J., Geng B., Weintraub N.L., Tang C. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart // J. Cardiovasc. Pharmacol. 2004. Vol. 43. Р. 165–170.
18. Marchesini G., Pagotto U., Bugianesi E., de Iasio R., Manini R., Vanni E., Pasquali R., Melchionda N., Rizzetto M. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance // J. Clin. Endocrinol. Metab. 2003. Vol. 88 (12). P. 5674–5679.
19. Schaller G., Schmidt A., Pleiner J., Woloszczuk W., Wolzt M., Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study // Diabetes. 2003. Vol. 52 (1). Р. 16–20.
20. Qarni A., Joatar F., Das N., Awad M., Eltayeb M., Al-Zubair A., Ali M., Masaud A., Shire A., Gumaa K., Giha H. Association of plasma ghrelin levels with insulin resistance in type 2 diabetes mellitus among Saudi subjects // Endocrinol. Metab (Seoul). 2017. Vol. 32 (2). Р. 230–240.
Review
For citations:
Belik E.V., Gruzdeva O.V., Dyleva Yu.A., Dolinchik T.R., Kuz'mina A.A., Bychkova E.E. DIAGNOSIS OF INSULIN RESISTANCE IN PATIENTS AT HIGH CARDIOVASCULAR RISK: FOCUS ON PEPTIDE HORMONE GHRELIN. Ateroscleroz. 2019;15(3):42-49. (In Russ.) https://doi.org/10.15372/ATER20190303
Views:
223
Email this article 